| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.004 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |